日韩在线视频不卡-日一区二区三区-天堂国产+人+综合+亚洲欧美-精品国产一区二区三区久久狼-国产成人无码18禁午夜福利网址-国产在线拍偷自揄拍精品-九色91丨porny丨丝袜-久久天天躁狠狠躁夜夜av-99蜜桃臀久久久欧美精品-成人一区二区视频-狠狠操人人干-40岁干柴烈火少妇高潮不断-国产福利不卡-伊人98-丰满多毛的陰户视频-日韩一二三四五区-国产专区一线二线三线码-好男人社区影院www-国产精品2019-欧美三级一区

Your Good Partner in Biology Research

SIGLEC8

SIGLEC8,全稱唾液酸結(jié)合免疫球蛋白樣凝集素8,是一種主要在免疫細(xì)胞表面表達(dá)的細(xì)胞表面受體。該蛋白常見別名為CD226,通過識別含有唾液酸的糖鏈結(jié)構(gòu),介導(dǎo)細(xì)胞與細(xì)胞或細(xì)胞與病原體間的相互作用,在免疫調(diào)節(jié)中發(fā)揮重要作用。SIGLEC8作為免疫抑制檢查點(diǎn)分子,能夠避免不必要的免疫反應(yīng),其細(xì)胞特異性表達(dá)特性及內(nèi)吞能力使其成為靶向藥物遞送的合適分子。研究表明,SIGLEC8與多種疾病密切相關(guān),包括自身免疫性疾病和癌癥。在自身免疫性疾病中,SIGLEC8的異常表達(dá)或功能可能導(dǎo)致免疫反應(yīng)失控,從而引發(fā)疾病;而在癌癥中,SIGLEC8的高表達(dá)與腫瘤細(xì)胞的免疫逃逸機(jī)制有關(guān)。針對SIGLEC8的藥物研發(fā)已取得一定進(jìn)展,例如抗SIGLEC-8單克隆抗體能夠通過抑制腫瘤細(xì)胞與免疫細(xì)胞的相互作用,增強(qiáng)抗腫瘤反應(yīng)。此外,基于SIGLEC8的抗體藥物、抗體-藥物偶聯(lián)物和嵌合抗原受體T細(xì)胞療法等新型治療策略也在臨床研究中展現(xiàn)出潛力。

熱銷產(chǎn)品

SIGLEC8 Recombinant Monoclonal Antibody (CSB-RA878931MA1HU)

驗(yàn)證數(shù)據(jù)

CSB-RA878931MA1HU

IHC image of CSB-RA878931MA1HU diluted at 1:100 and staining in paraffin-embedded human prostate cancer performed on a Leica BondTM system. After dewaxing and hydration, antigen retrieval was mediated by high pressure in a citrate buffer (pH 6.0). Section was blocked with 10% normal goat serum 30min at RT. Then primary antibody (1% BSA) was incubated at 4°C overnight. The primary is detected by a Goat anti-human polymer IgG labeled by HRP and visualized using 0.05% DAB.

Human Sialic acid-binding Ig-like lectin 8(SIGLEC8) ELISA kit (CSB-EL021302HU)

驗(yàn)證數(shù)據(jù)

CSB-EL021302HU 標(biāo)準(zhǔn)曲線

貨號:CSB-EL021302HU

規(guī)格:96T/48T

靈敏度:0.039 ng/mL

檢測范圍:0.156 ng/mL-10 ng/mL

These standard curves are provided for demonstration only. A standard curve should be generated for each set of samples assayed.

SIGLEC8 Antibodies

SIGLEC8 for Homo sapiens (Human)

SIGLEC8 Proteins

SIGLEC8 Proteins for Homo sapiens (Human)

SIGLEC8 ELISA Kit

SIGLEC8 ELISA Kit for Homo sapiens (Human)